Vaccine boosters help keep cancer patients from being hospitalized or admitted to intensive care units due to COVID-19, according to a new study led by Cedars-Sinai investigators.

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

Many patients experience long-lasting health problems after COVID-19. The study aimed to assess 3-year trajectories of a comprehensive set of patient-reported outcome measures (PROMs) in patients ...

Added value of this study To the best of our knowledge, this study is the largest randomised clinical trial assessing the effect of hydroxychloroquine versus placebo added to a standard of care ...

There will probably never be a perfect treatment to cure COVID-19—but the right medications for the right patients can save lives.

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Novel Coronavirus (COVID-19) : Coronavirus : The explosive rise in cases of coronavirus infection is of concern worldwide. Stay up-to-date here.

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's ...

According to a study published in JAMA Network Open, 70% of U.S. adults would conduct a home test for suspected COVID-19.

Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 ... efficacy data from the phase three trial on its stand-alone flu vaccine. That ...

Although treating COVID-19 with TCZ is an off-label use, it may be relatively appropriate and safe in coping with COVID-19 associated cytokine storm basing on the current evidence.